Legal & General Group’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-175
Closed -$8K 3497
2021
Q2
$8K Sell
175
-355
-67% -$17.6K ﹤0.01% 3436
2021
Q1
$29K Buy
530
+27
+5% +$1.79K ﹤0.01% 2997
2020
Q4
$37K Hold
503
﹤0.01% 2887
2020
Q3
$100K Sell
503
-105
-17% -$26.4K ﹤0.01% 2490
2020
Q2
$170K Buy
608
+73
+14% +$17K ﹤0.01% 2392
2020
Q1
$95K Sell
535
-34
-6% -$7.29K ﹤0.01% 2426
2019
Q4
$140K Buy
569
+6
+1% +$1.1K ﹤0.01% 2491
2019
Q3
$66K Buy
563
+175
+45% +$26.5K ﹤0.01% 2650
2019
Q2
$63K Buy
388
+48
+14% +$9.12K ﹤0.01% 2678
2019
Q1
$80K Buy
340
+19
+6% +$4.81K ﹤0.01% 2558
2018
Q4
$87K Buy
321
+47
+17% +$13.6K ﹤0.01% 2493
2018
Q3
$122K Buy
274
+51
+23% +$23.9K ﹤0.01% 2460
2018
Q2
$105K Sell
223
-26
-10% -$13.7K ﹤0.01% 2485
2018
Q1
$146K Sell
249
-70
-22% -$43.4K ﹤0.01% 2369
2017
Q4
$171K Sell
319
-30
-9% -$13.6K ﹤0.01% 2378
2017
Q3
$145K Sell
349
-503
-59% -$154K ﹤0.01% 2450
2017
Q2
$212K Buy
+852
New +$240K ﹤0.01% 2280

Other funds holding ASMB

Legal & General Group's ASMB Position: Q3 2021 in Review

Legal & General Group sold out of Assembly Biosciences (ASMB) in Q3 2021, closing a stake of 175 shares — an estimated $8K sold.

Legal & General Group first reported a position in ASMB in Q2 2017 and held it in 17 quarters. The position peaked at $212K in Q2 2017. 65 funds tracked by Wall St. Rank hold ASMB as of Q3 2021.

  • Legal & General Group reported no remaining Assembly Biosciences position as of Q3 2021 after selling out during the quarter.
  • Legal & General Group sold 175 Assembly Biosciences shares in Q3 2021, an estimated $8K.
  • Legal & General Group first reported a position in Assembly Biosciences in Q2 2017 and held it in 17 quarters.
  • Legal & General Group's Assembly Biosciences position peaked at $212K in Q2 2017.
  • 65 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2021.

Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.